⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRNA News
Moderna, Inc. Common Stock
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
accessnewswire.com
MRNA
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
accessnewswire.com
MRNA
Global CD70-Targeting Therapies Market Report 2026 - Highlights Clinical Innovation, Pipeline Trends and Commercial Opportunities
globenewswire.com
ALLO
CRSP
JNJ
PFE
ADCT
REGN
MRNA
BMY
GILD
AMGN
BIIB
AZN
NVS
LLY
ABBV
Global mRNA Cancer Vaccines Market Report 2026-2031: Assesses More Than 70 Vaccines Through Phase III
globenewswire.com
BNTX
MRNA
CVAC
TRNS
mRNA Therapeutics Market Outlook Report 2026-2035 Featuring Profiles of Arcturus Therapeutics, BioNTech, CureVac, Moderna, Providence Therapeutics, RNAimmune, Recode Therapeutics, and More
globenewswire.com
ARCT
BNTX
MRNA
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
globenewswire.com
SBFM
BNTX
AZN
MRNA
BMY
Workato Launches Otto for Everyone, AI Superagents That Run Whole Projects Start to Finish
businesswire.com
AMZN
CSCO
NVDA
GOOG
MSFT
IBM
ORCL
CRM
INTC
AMD
MU
QCOM
AAPL
META
NFLX
GOOGL
AMPL
SPCE
TSLA
BNTX
CRSP
EDIT
GILD
MRNA
REGN
VRTX
BIIB
AMGN
NCLH
CCL
RCL
XOM
CVX
SHEL
T
VZ
TMUS
NKE
DIS
MCD
KO
PEP
WMT
HD
JNJ
PG
UNH
MA
V
BOX
SHOP
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
XOM
JPM
AMD
PYPL
MRNA
MSTR
SNOW
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
INTC
Global RNAi Technology Market is Expected to Showcase Significant Growth at a CAGR of ~14% by 2034 | DelveInsight
globenewswire.com
BNTX
MRNA
DVAX
ALNY
BIIB
IONS
ARCT
VRTX
PFE
SGMO
AZN
CAT
TMO
LH
BreakBio, the Third Player in Personalized Drugs, Enters the Clinic
prnewswire.com
MRNA
BNTX